The estimated Net Worth of Jayson Donald Alexander Dallas is at least $1.36 Milión dollars as of 11 June 2021. Jayson Dallas owns over 1,223 units of Arena Pharmaceuticals Inc stock worth over $715,128 and over the last 9 years he sold ARNA stock worth over $273,229. In addition, he makes $372,633 as Independent Director at Arena Pharmaceuticals Inc.
Jayson has made over 7 trades of the Arena Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,223 units of ARNA stock worth $81,158 on 11 June 2021.
The largest trade he's ever made was buying 3,650 units of Arena Pharmaceuticals Inc stock on 19 November 2018 worth over $100,594. On average, Jayson trades about 274 units every 25 days since 2015. As of 11 June 2021 he still owns at least 7,152 units of Arena Pharmaceuticals Inc stock.
You can see the complete history of Jayson Dallas stock trades at the bottom of the page.
Dr. Jayson D.A. Dallas M.D. serves as Independent Director of the Company. Dr. Dallas has served on our Board of Directors since February 2017. He has served as President and Chief Executive Officer of Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, since June 2018. Prior to joining Aimmune, he served as the first Chief Commercial Officer and Executive Vice President of Ultragenyx Pharmaceutical, Inc., a publicly held biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, since August 2015. Prior to Ultragenyx, Dr. Dallas served as General Manager of Roche, a healthcare company, in the United Kingdom from January 2013 to July 2015. Before joining Roche, he held two different positions at Genentech, a pharmaceutical company, as Head of Global Oncology Launch Excellence and Biosimilar Strategy and Head of Global Product Strategy for Immunology and Ophthalmology, from May 2010 to December 2012 in South San Francisco. Earlier in his career, Dr. Dallas worked at Novartis and Pfizer / Pharmacia in the United States and previously at Roche in Switzerland. Dr. Dallas holds an M.D. from the University of the Witwatersrand, Johannesburg, South Africa and an M.B.A. from Ashridge Business School in the United Kingdom.
As the Independent Director of Arena Pharmaceuticals Inc, the total compensation of Jayson Dallas at Arena Pharmaceuticals Inc is $372,633. There are 10 executives at Arena Pharmaceuticals Inc getting paid more, with Amit Munshi having the highest compensation of $8,931,400.
Jayson Dallas is 52, he's been the Independent Director of Arena Pharmaceuticals Inc since 2017. There are 11 older and 2 younger executives at Arena Pharmaceuticals Inc. The oldest executive at Arena Pharmaceuticals Inc is Garry Neil, 67, who is the Independent Director.
Jayson's mailing address filed with the SEC is OLE MAALOES VEJ 3, C/O GALECTO, INC., COPENHAGEN N G7, G7, DK-2200.
Over the last 21 years, insiders at Arena Pharmaceuticals Inc have traded over $9,243,184 worth of Arena Pharmaceuticals Inc stock and bought 78,040 units worth $252,505 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Manmeet Singh Soni a Garry Arthur Neil. On average, Arena Pharmaceuticals Inc executives and independent directors trade stock every 39 days with the average trade being worth of $3,133,387. The most recent stock trade was executed by Amit Munshi on 16 August 2021, trading 1,000 units of ARNA stock currently worth $48,190.
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Arena Pharmaceuticals Inc executives and other stock owners filed with the SEC include: